PR Title: |
Emerging Biopharmaceutical Markets to Exceed US$ 13.6 Billion by 2015 |
PR Summary: |
IMARC Group, one of the world's leading research and advisory firms, finds that the sales of Biopharmaceuticals in Emerging markets will nearly triple its size from US$ 5.3 Billion in 2010 to US$ 13.5 Billion in 2015. |